Osteoglycin deficiency does not affect atherosclerosis in mice
- 1 December 2014
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 237 (2) , 418-425
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Decorin Mimic Inhibits Vascular Smooth Muscle Proliferation and MigrationPLOS ONE, 2013
- Role of Osteoglycin in the Linkage between Muscle and BoneJournal of Biological Chemistry, 2012
- Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in AtherosclerosisJournal of Vascular Research, 2009
- The matricellular functions of small leucine-rich proteoglycans (SLRPs)Journal of Cell Communication and Signaling, 2009
- Genetic Evidence for the Coordinated Regulation of Collagen Fibrillogenesis in the Cornea by Decorin and BiglycanJournal of Biological Chemistry, 2009
- The proteoglycan osteoglycin/mimecan is correlated with arteriogenesisMolecular and Cellular Biochemistry, 2008
- Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular massNature Genetics, 2008
- Expression studies of osteoglycin/mimecan (OGN) in the cochlea and auditory phenotype of Ogn-deficient miceHearing Research, 2007
- Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient miceAtherosclerosis, 2006
- Effect of low-level laser irradiation on osteoglycin gene expression in osteoblastsLasers in Medical Science, 2003